- Home
- SRZN vs QNBC Comparison
SRZN vs QNBC Comparison
Compare SRZN & QNBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SRZN | QNBC |
|---|---|---|
| Founded | 2015 | 1877 |
| Country | United States | United States |
| Employees | 59 | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 276.3M | 296.1M |
| IPO Year | 2020 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SRZN | QNBC |
|---|---|---|
| Price | $31.50 | $47.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $63.50 | N/A |
| AVG Volume (30 Days) | ★ 272.4K | 66.3K |
| Earning Date | 11-09-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 3.30% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,477,000.00 | N/A |
| Revenue This Year | $187.60 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.52 | $44.75 |
| 52 Week High | $37.83 | $48.75 |
Technical Indicators
Market Signals| Indicator | SRZN | QNBC |
|---|---|---|
| Relative Strength Index (RSI) | 59.12 | 61.53 |
| Support Level | $22.61 | $46.40 |
| Resistance Level | $33.96 | $48.75 |
| Average True Range (ATR) | 2.22 | 0.93 |
| MACD | 0.14 | -0.00 |
| Stochastic Oscillator | 65.22 | 55.83 |
Price Performance
Historical ComparisonAbout SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
About QNBC QNB Corp. Common Stock
QNB Corp is a bank holding company based in the United States. It operates through its wholly-owned subsidiary, which engages in the general commercial banking business and offers a full range of banking services to its customers. Its business activities involve attracting deposits and using funds in making commercial loans, residential mortgage loans, consumer loans, and purchasing investment securities. The loan portfolio includes commercial loans, such as commercial and industrial, construction, and loans secured by commercial real estate and residential real estate, and retail loans, including home equity loans and lines, and consumer loans. It generates revenue from net interest income.